Skip to main content

Advertisement

Log in

Drugs Related to Oropharyngeal Dysphagia in Older People

  • Original Article
  • Published:
Dysphagia Aims and scope Submit manuscript

Abstract

Scientific evidence on the impact of medication on the physiology of swallowing is scarce and mainly based on clinical case reports. To evaluate the association between oropharyngeal dysphagia (OD) and chronic exposure to medication in older patients admitted to the acute geriatric unit (AGU) of a secondary hospital, we performed a retrospective cross-sectional study of 966 patients admitted to an AGU from 2008 to 2011. We reviewed (a) diagnosis of OD (assessed with the volume-viscosity swallow test, V- VST); (b) chronic patient medication classified by anatomical, therapeutic, chemical codes; and (c) demographic and clinical data. A univariate analysis was performed to determine which medications were associated with OD. A multivariate analysis adjusting for confounding clinical factors was performed to identify which of those medications were independently associated with OD. The age of patients included was 85.3 ± 6.37 years and 59.4 % were women. A total of 41.9 % presented OD. We found a possible protective effect of beta blocking agents on OD after the multivariate analysis (OR 0.54, 95 % CI 0.35–0.85). None of the categories of drugs was associated with an altered swallowing function after adjusting for confounding variables. The present study is the first one to widely investigate the association between drugs and OD, increasing understanding of their association. The role of beta blockers in OD needs to be further studied as their potentially beneficial effects on the swallowing function in older patients could help to prevent complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nogueira D, Reis E. Swallowing disorders in nursing home residents: how can the problem be explained? Clinl Interv Aging. 2013;8:221–7.

    Google Scholar 

  2. Cabré M, Serra-Prat M, Force L, Almirall J, Palomera E, Clavé P. Oropharyngeal Dysphagia is a risk factor for readmission for pneumonia in the very elderly persons: observational propsective study. J Gerontol A Biol Sci Med. 2014;69:330–7.

    Google Scholar 

  3. Serra-Prat M, Hinojosa G, López D, et al. Prevalence of oropharyngeal dysphagia and impaired safety and efficacy of swallow in independently living older persons. J Am Geriatr Soc. 2011;59(1):186–7.

    PubMed  Google Scholar 

  4. Smithard D, O’Neill P, Parks C, et al. Complications and outcome after acute stroke. Does dysphagia matter? Stroke. 1996;27:1200–4.

    CAS  PubMed  Google Scholar 

  5. Finestone H, Greene-Finestone L, Wilson E, et al. Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil. 1996;77:340–5.

    CAS  PubMed  Google Scholar 

  6. Teasell R, McRae M, Marchuk Y, et al. Pneumonia associated with aspiration following stroke. Arch Phys Med Rehabil. 1996;77:707–9.

    CAS  PubMed  Google Scholar 

  7. Murry T, Carrau R. Clinical management of swallowing disorders. 3rd ed. San Diego: Plural; 2012.

    Google Scholar 

  8. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124:328–36.

    PubMed  Google Scholar 

  9. Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001;81:929–69.

    CAS  PubMed  Google Scholar 

  10. Ertekin C, Aydogdu I. Neurophysiology of swallowing. Clin Neurophysiol. 2003;114:2226–44.

    PubMed  Google Scholar 

  11. Carl LL, Johnson PR. Drugs and dysphagia: how medications can affect eating and swallowing. 1st ed. Austin: Pro-Ed; 2006.

    Google Scholar 

  12. Bieger D, Neuhuber W. Neural circuits and mediators regulating swallowing in the brainstem. GI Motility online, 2006. http://www.nature.com/gimo/contents/pt1/full/gimo74.html. Accessed 04 June 2015

  13. Dziewas R, Warnecke T, Schnabel M, et al. Neuroleptic-induced dysphagia: case report and literature review. Dysphagia. 2007;22(1):63–7.

    PubMed  Google Scholar 

  14. Sokoloff LG, Pavlakovic R. Neuroleptic-induced dysphagia. Dysphagia. 1997;12(4):177–9.

    CAS  PubMed  Google Scholar 

  15. Jt Stewart. Dysphagia associated with risperidone therpay. Dysphagia. 2003;18:274–5.

    Google Scholar 

  16. Loeb M, Becker M, Eady A, et al. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. 2003;51(7):1018–22.

    PubMed  Google Scholar 

  17. Fonda D, Schwarts J, Clinnick S. Parkinsonian medication one hour before meals improves symptomatic swallowing: a case study. Dysphagia. 1995;10:165–6.

    CAS  PubMed  Google Scholar 

  18. American Speech-Language-Hearing Association. Guidelines for speech-language pathologists performing videofluoroscopic swallowing studies. ASHA Suppl. 2004;24:77–92.

    Google Scholar 

  19. Ebihara T, Takahashi H, Ebihara S, et al. Capsaicin troche for swallowing dysfunction in older people. J Am Geriatr Soc. 2005;53(5):824–8.

    PubMed  Google Scholar 

  20. Ebihara T, Sekizawa K, Nakazawa H, Sasaki H. Capsaicin and swallowing reflex. Lancet. 1994;341:432.

    Google Scholar 

  21. Ebihara T, Ebihara S, Maruyama M, et al. A randomized trial of olfactory stimulation using black pepper oil in older people with swallowing dysfunction. J Am Geriatr Soc. 2006;54(9):1401–6.

    PubMed  Google Scholar 

  22. Rofes L, Arreola V, Martin A, Clavé P. Natural capsaicinoids improve swallow response in older patients with oropharyngeal dysphagia. Gut. 2013;62(9):1280–7.

    PubMed  Google Scholar 

  23. Rofes L, Arreola V, Martin A, Clavé P. Effect of oral piperine on the swallow response of patients with oropharyngeal dysphagia. J Gastroenterol. 2014;49(12):1517–23.

    PubMed  Google Scholar 

  24. Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113(5):1425.

    CAS  PubMed  Google Scholar 

  25. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet. 1998;352:1069.

    CAS  PubMed  Google Scholar 

  26. Cabré M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing. 2010;39:39–45.

    PubMed  Google Scholar 

  27. Charlson M, Pompei P, Ales K, Mackenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    CAS  PubMed  Google Scholar 

  28. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–5.

    CAS  PubMed  Google Scholar 

  29. WHO (2015) The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). World Health Organization. http://www.who.int/classifications/atcddd/en/. Accessed 01 Oct 2015

  30. Clavé P, Arreola V, Romea M, Medina L, Palomera E, Serra-Prat M. Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration. Clin Nutr. 2008;27:806.

    PubMed  Google Scholar 

  31. Stewart JT. Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc. 2001;49:1260–1.

    CAS  PubMed  Google Scholar 

  32. Bashford G, Bradd P. Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol. 1996;9(3):133–5.

    CAS  PubMed  Google Scholar 

  33. Gonzalez F. Extrapyramidal syndrome presenting as dysphagia: a case report. Am J Hosp Palliat Care. 2008;25:398–400.

    PubMed  Google Scholar 

  34. Brandt N. Medications and dysphagia: How do they impact each other? Nutr Clin Pract. 1999;14:S27–30.

    Google Scholar 

  35. Korsten M, Rosman A, Fishbein S, Shlein R, Goldberg H, Biener A. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med. 1991;90(6):701–6.

    CAS  PubMed  Google Scholar 

  36. Sukys-Claudino L, Moraes W, Guilleminault C, Tufik S, Poyares D. Beneficial effect of donepezil on obstructive sleep apnea: a double-blind, placebo-controlled clinical trial. Sleep Med. 2012;13(3):290–6.

    PubMed  Google Scholar 

  37. Dantas R, Souza R. Dysphagia induced by chronic ingestion of benzodiazepine. Am J Gastroenterol. 1997;92(7):1194–6.

    CAS  PubMed  Google Scholar 

  38. Almirall J, Rofes L, Serra-Prat M, et al. Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J. 2013;41(4):923–8.

    PubMed  Google Scholar 

  39. Gaillard JM Benzodiazepines and GABA-ergic transmisión. In: Kryger MH, Roth T. Dement WC. (eds.) Principles and practie of sleep Medicine. Philadelphia. P. WB Saunders, 1989. pp. 213–218.

  40. Almirall J, Serra-Prat M, Baron F, Palomera E, Bolíbar I. The use of benzodiazepines could be a protective factor for community-acquired pneumonia in <60-year-old subjects. Thorax. 2013;68:965–6.

    Google Scholar 

  41. Almirall J, Bolíbar I, Serra-Prat M, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008;31:1274–84.

    CAS  PubMed  Google Scholar 

  42. Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, et al. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med. 2011;3:82ra37.

    PubMed  PubMed Central  Google Scholar 

  43. Murphy R, Gardiner P, Rousseau G, Bouvier M, Béliveau L. Chronic β-blockade increases skeletal muscle β-adrenergicreceptor density and enhances contractile force. J Appl Physiol. 1997;83(2):459–65.

    CAS  PubMed  Google Scholar 

  44. Bradley W, Daroff R, Fenichel G, Jankovic J. Neurology in clinical practice, the neurological disorders. JAMA. 2001;285(4):172.

    Google Scholar 

  45. Shimizu T, Fujioka S, Otonashi H, Kondo M, Sekizawa K. ACE inhibitor and swallowing difficulties in stroke. A preliminary study. J Neurol. 2008;255(2):288–9.

    CAS  PubMed  Google Scholar 

  46. Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet. 1998;352:1937–8.

    CAS  PubMed  Google Scholar 

  47. Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113:1425.

    CAS  PubMed  Google Scholar 

  48. Perez I, Smithard DG, Davies H, et al. Pharmacological treatment of dysphagia in stroke. Dysphagia. 1998;13:12–6.

    CAS  PubMed  Google Scholar 

  49. Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 2004;169(9):1041–5.

    PubMed  Google Scholar 

Download references

Acknowledgments

We thank Jane Lewis for reviewing the English of the manuscript. This work has been conducted within the framework of a doctoral thesis in medicine from the Autonomous University of Barcelona.

Author Contributions

MM and LR: designed and coordinated the study and drafted the manuscript; LC: critical input and revision of the manuscript; EP and MSP: statistical analysis and revision of the manuscript; MC: collected the data. All authors approved the final version of the article.

Financial Support

None of the authors have any conflict of interest nor have received any funding related to the present study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marta Miarons.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miarons, M., Campins, L., Palomera, E. et al. Drugs Related to Oropharyngeal Dysphagia in Older People. Dysphagia 31, 697–705 (2016). https://doi.org/10.1007/s00455-016-9735-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00455-016-9735-5

Keywords

Navigation